Welcome to our dedicated page for Mannatech news (Ticker: MTEX), a resource for investors and traders seeking the latest updates and insights on Mannatech stock.
Mannatech Incorporated (MTEX) provides science-backed wellness solutions through nutritional supplements and skincare products across global markets. This page serves as the definitive source for official company announcements and market-relevant developments.
Investors and industry observers will find curated press releases covering financial results, product innovations, regulatory updates, and leadership changes. All content is maintained to reflect MTEX's position in the competitive wellness sector and its direct-to-consumer business model.
Key updates include earnings reports, research advancements in natural health formulations, and strategic partnerships. Regular monitoring of this resource enables stakeholders to track operational milestones and market expansion efforts across the Americas, EMEA, and Asia/Pacific regions.
Bookmark this page for streamlined access to MTEX's evolving corporate narrative. Combine these primary sources with broader market data for informed analysis of this wellness industry innovator.
Mannatech declared a cash dividend of $1.70 per share, payable on December 29, 2021, to shareholders of record on December 15, 2021. This dividend includes a quarterly portion of $0.20 and a special dividend of $1.50, highlighting the company's commitment to shareholder value. CEO Alfredo Bala emphasized the intent to reward and encourage long-term investment in Mannatech. With over 25 years in business and a presence in 25 markets, the company continues focusing on health and wellness products.
Mannatech reported third quarter 2021 net sales of $39.4 million, a 3.9% increase from $38.0 million in Q3 2020. Income from operations rose to $3.3 million, compared to $1.4 million in the prior year. Net income reached $2.9 million, or $1.44 per diluted share, up from $1.6 million, or $0.76 per diluted share in Q3 2020. Year-to-date sales were $120.3 million, a 7.2% increase year-over-year. Recruitment of independent associates declined by 1.4% to 25,036 in Q3 2021.
Mannatech, Incorporated (NASDAQ: MTEX) has approved a share repurchase program to buy back up to $1.0 million of its outstanding common stock. The repurchase will occur in the open market or through negotiated transactions at management's discretion, influenced by market conditions. This initiative begins on September 21, 2021, and concludes either on September 21, 2022, or upon reaching the purchase limit. Mannatech plans to finance the repurchases using available cash, aiming to enhance shareholder value.
Mannatech, Incorporated (NASDAQ: MTEX) has declared a cash dividend of $0.20 per share, payable on September 29, 2021. This dividend is aimed at rewarding shareholders and promoting long-term investment. Shareholders on record as of September 15, 2021 will receive this dividend. CEO Alfredo 'Al' Bala emphasized the company's commitment to delivering value to its investors. Mannatech operates globally in the health and wellness sector, offering products through independent associates in over 25 markets.
Mannatech, Incorporated (NASDAQ: MTEX) reported a strong second quarter for 2021, achieving net sales of $42.5 million, a 12.9% increase from $37.6 million in Q2 2020. Operating income rose to $2.0 million from $1.1 million, while net income reached $2.1 million or $0.99 per diluted share, up from $1.1 million or $0.47 per share in the previous year. Recruitment of independent associates increased by 13.0% to 21,527. However, selling and administrative expenses also rose to $7.6 million.
Mannatech, Incorporated (NASDAQ: MTEX) announced the completion of its cash tender offer, which concluded on June 25, 2021. The company purchased 171,433 shares of its common stock at $26.00 per share, totaling approximately $4.46 million. This represents around 8.31% of its total outstanding shares as of April 30, 2021. The purchase was funded through the company's cash reserves. Mannatech is devoted to enhancing lives with its health and wellness products through a network of independent associates.
Mannatech (NASDAQ: MTEX) announced preliminary results of its cash tender offer to repurchase up to 211,538 shares at $26.00 each, which expired on June 25, 2021. A total of 169,622 shares were properly tendered, with the company expected to accept for payment 174,249 shares at a total cost of approximately $4.5 million, representing around 8.45% of its total outstanding shares. The purchase will be funded from cash on hand. Final numbers will be confirmed following a guaranteed delivery period.
Mannatech (MTEX) reported that its shareholders approved all proposals during the annual shareholder meeting on June 15, 2021. Approximately 70.3% of the 2,063,280 outstanding shares were represented. Key decisions included the election of Larry A. Jobe and Kevin Robbins to the Board of Directors, the ratification of BDO USA, LLP as the independent auditor for the fiscal year 2021, and the advisory approval of executive compensation.
Al Bala, the President and CEO of Mannatech, has been elected to the Board of Directors of the Direct Selling Association (DSA). This is a significant recognition within the direct selling industry. Bala will serve a two-year term, aiming to promote integrity within the sector. He expressed gratitude for the opportunity, reflecting on his personal journey from factory worker to CEO. Mannatech, operational for over 25 years, focuses on health, weight management, fitness, and skincare products through its independent associates.
Mannatech (MTEX) announced a cash tender offer to purchase up to 211,538 shares of its common stock at $26.00 each. The offer aligns with the company's goal to maximize shareholder value, allowing for liquidity and enhanced future earnings potential for remaining shareholders. The tender offer is not contingent on financing and is subject to certain conditions outlined in the SEC filings. This announcement follows a closing share price of $19.84 on May 26, 2021, indicating an increase in value for those participating in the tender offer.
